Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen
Clinical trial NCT05502341 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05502341
- Sponsor
- Gilead Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-16
- Primary completion
- 2025-09-29
- Enrollment
- 689
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.